--- type: "example" title: "Evidence Example: evidence-example-stroke-no-alteplase-fatalICH" resource: "Evidence" example: "evidence-example-stroke-no-alteplase-fatalICH" --- # Evidence Example: evidence-example-stroke-no-alteplase-fatalICH ## Narrative "Risk of fatal ICH without alteplase for stroke" is a univariate risk estimate. ## Example XML ```xml

"Risk of fatal ICH without alteplase for stroke" is a univariate risk estimate.

<status value="draft"/> <relatesTo> <type> <coding> <system value="http://terminology.hl7.org/CodeSystem/artifact-relationship-type" /> <code value="cites" /> <display value="Cites" /> </coding> </type> <targetMarkdown value="Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. <b>Citation:</b> Emberson J, Lees KR, Lyden P, Blackwell L, Albers G, Bluhmki E, et al;Stroke Thrombolysis Trialists' Collaborative Group. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 2014 Nov 29;384(9958):1929-35 PMID 25106063 <b>URL:</b> https://doi.org/10.1016/S0140-6736(14)60584-5"/> </relatesTo> <description value="0.4% incidence of fatal intracranial hemorrhage within 7 days without alteplase in patients with acute ischemic stroke"/> <variableDefinition> <variableRole value="population"/> <observed> <reference value="Group/Emberson-2014-IPD-MA-No-Alteplase-Cohort"/> <type value="Group"/> <display value="Emberson 2014 IPD-MA No Alteplase Cohort"/> </observed> <intended> <reference value="Group/AcuteIschemicStrokeTreatedWithoutAlteplase"/> <type value="Group"/> <display value="adults with acute ischemic stroke treated without alteplase"/> </intended> </variableDefinition> <variableDefinition> <variableRole value="outcome"/> <observed> <reference value="EvidenceVariable/example-fatal-ICH-in-7-days"/> <type value="EvidenceVariable"/> <display value="fatal ICH"/> </observed> <intended> <reference value="EvidenceVariable/example-fatal-ICH-in-7-days"/> <type value="EvidenceVariable"/> <display value="fatal ICH"/> </intended> </variableDefinition> <synthesisType> <coding> <system value="http://terminology.hl7.org/CodeSystem/synthesis-type"/> <code value="IPD-MA"/> <display value="individual patient data meta-analysis"/> </coding> </synthesisType> <studyDesign> <coding> <system value="https://fevir.net/sevco"/> <code value="SEVCO:01003"/> <display value="randomized assignment"/> </coding> </studyDesign> <statistic> <statisticType> <coding> <system value="https://fevir.net/sevco"/> <code value="STATO:0000607"/> <display value="proportion"/> </coding> </statisticType> <quantity> <value value="0.00386298627"/> </quantity> <numberOfEvents value="13"/> <sampleSize> <numberOfStudies value="9"/> <numberOfParticipants value="3365"/> </sampleSize> </statistic> </Evidence> ```